Weekly Paclitaxel Versus Three-Weekly Paclitaxel in Recurrent Platinum-Resistant Epithelial Ovarian and Peritoneal Cancers: A Phase III Study
about
Weekly nanoparticle albumin-bound paclitaxel in combination with cisplatin versus weekly solvent-based paclitaxel plus cisplatin as first-line therapy in Chinese patients with advanced esophageal squamous cell carcinomaOvercoming platinum resistance in ovarian cancer treatment: from clinical practice to emerging chemical therapies.
P2860
Weekly Paclitaxel Versus Three-Weekly Paclitaxel in Recurrent Platinum-Resistant Epithelial Ovarian and Peritoneal Cancers: A Phase III Study
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Weekly Paclitaxel Versus Three ...... eal Cancers: A Phase III Study
@en
type
label
Weekly Paclitaxel Versus Three ...... eal Cancers: A Phase III Study
@en
prefLabel
Weekly Paclitaxel Versus Three ...... eal Cancers: A Phase III Study
@en
P2860
P356
P1476
Weekly Paclitaxel Versus Three ...... eal Cancers: A Phase III Study
@en
P2093
Khalid E Nasr
Mohammad S Elkady
P2860
P356
10.4137/CMO.S38204
P407
P577
2016-04-25T00:00:00Z